About Neurent Medical

Brian Shields is a founder and the CEO of Neurent Medical. Previously, Brian worked as a management consultant much of this time spent on the design and commercial rollout of connected health clinical programs in public and private European health systems. Brian was a fellow of the BioInnovate Ireland fellowship program in Galway, Ireland, in 2014, where the earliest concepts of the NEUROMARK product were developed. Since then, Brian has built an world class team and led the company through multiple Venture Capital financing transactions to bring NEUROMARK from concept to US commercialization. Brian has a PhD in Applied Computing and an MBA.

Declan is the CFO of Neurent Medical. Declan has significant senior executive experience in the medical device, biotechnology and healthcare sectors in the US and Ireland. Previously Declan has served as the CFO of INAMED Corporation (NASDAQ: IMDC) and Fibrocell Science, Inc. (NYSE MKT: FCSC) where he raised in excess of US$250 million in financing and managed a US$3.2 billion M&A transaction. Mr. Daly began his career in PricewaterhouseCoopers in Dublin and subsequently worked in PricewaterhouseCoopers in London and BDO in Dublin.

Declan is a Fellow of Chartered Accountants Ireland. He has a B.A. (Moderatorship) degree in Management Science & Information System Studies from Trinity College, Dublin and a Professional Diploma in Accounting from Dublin City University.

John has over 10 years of medical device industry experience in sales management, strategy and product marketing, business development, and finance. Prior to Neurent Medical, John spent 3 years at Tactile Medical leading sales and business development activities. John has extensive ENT experience including serving as VP of Business Development for Entellus Medical during their acquisition of Spirox and sale to Stryker and Director of Business Development and Portfolio Strategy for Stryker ENT including the acquisition of Arrinex. John started his career at Piper Sandler in the Med Tech investment banking and capital markets groups. John received his BA from St. Olaf College in Biology and Economics.

Karen is responsible for clinical, regulatory, and quality at Neurent Medical. Karen has significant executive leadership experience in the medical device industry in the areas of clinical, regulatory, and quality for both large and start-up companies, including ten years in the ENT space. She has a successful track record in designing and running clinical studies, obtaining positive clinical study outcomes, obtaining numerous FDA and worldwide regulatory approvals, and ensuring successful QMS audits. Karen holds a Master of Science degree in Biometry and Health Information Systems from the University of Minnesota, and a Bachelor of Science degree from the University of Wisconsin.

Steven leads R&D for Neurent Medical. He has extensive experience leading R&D programs across a number of areas of interventional medicine. The inventor on over 50 granted patents, he has a strong track record of developing sophisticated medical devices, from early proof of concept stage to regulatory approval and commercialization. Prior to Neurent Medical, he was R&D Director at Boston Scientific following the acquisition of Novate Medical/BTG. Steven holds a Bachelor of Science in Polymer Engineering.

Monica Cipollo is an innovative leader with over 20 years of experience driving growth and delivering results in competitive healthcare and medical device markets. With a track record of crafting evidence-based marketing strategies and executing successful product launches in both pharma and medtech. Monica specializes in strategic business planning, digital marketing, and cross-functional collaboration, leveraging analytics to influence behavior and uncover key opportunities. Her expertise extends to both HCP and patient engagement, exemplified by her work on the commercial launches at Novartis, Sunovion Pharmaceuticals, Depuy Synthes (JnJ MedTech), and now Neurent Medical. She holds a Master of Business Administration from Curry College and a Bachelor of Science from Saint Joseph’s University.

Fergal is responsible for supply chain, manufacturing operations and commercial operations at Neurent Medical. Fergal has significant leadership experience in the medical device industry with a 27 year track record spanning operations, procurement, commercial management and engineering with a focus on interventional medical products for global markets. Fergal began his career at Boston Scientific before joining Creganna Medical, which was later acquired by TE Connectivity. Prior to joining Neurent Medical, he served as Director of Global Procurement where he led procurement across all global manufacturing sites in TE’s medical business unit. Fergal holds a degree in Mechanical Engineering from the University of Limerick and a Post Graduate Diploma in International Selling from Technological University Dublin.

Annalise is the Director of Clinical Operations at Neurent Medical, with over 15 years of experience managing and executing clinical trials. She has worked on more than 95 clinical trials, including nine years focused on research in sinonasal and respiratory diseases. She has held leadership roles at research sites, contract research organizations, and research sponsors, spanning both startups and multinational corporations. Annalise has expertise in all phases of clinical trial development and conduct for non-significant risk studies, FDA Investigational Device Exemptions, and Health Canada Investigational Testing Authorizations. She holds a Bachelor of Science in Nursing from the University of Colorado, Anschutz Medical Campus.

Kenny is responsible for quality and regulatory affairs at Neurent Medical. He has significant leadership experience in the medical device industry, particularly in regulatory affairs and quality management systems, primarily within start-up companies. His experience also includes acquisitions and integration into multi-national organizations. Kenny has a proven track record with successful regulatory filings, including 510k, PMA, CE Marking, and international registrations, including Japan. He excels in developing quality management systems to comply with various standards and regulations and has led teams through successful audits by the FDA, notified bodies, competent authorities, and the PMDA.